AstraZeneca Pharma India Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
ASTRAZEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
AstraZeneca Pharma India has submitted a routine compliance certificate to the stock exchanges. The certificate, dated June 4, 2025, was issued by Integrated Registry Management Services Private Limited, the company's Registrar and Transfer Agent (RTA). It confirms compliance with Regulation 74(5) of the SEBI Depositories Regulations, which pertains to the timely confirmation of dematerialisation (conversion of physical shares into electronic/demat form) requests. This is a standard regulatory filing submitted by the company secretary.
This is a routine administrative compliance filing with no material impact on shareholders or the company's business or stock price. It simply confirms that share dematerialisation activities are being processed properly by the RTA as required by SEBI rules.